MERCK & CO., INC. (MRK)
Clinical trial NCT06814145 updates: 1. completion date: 2029-03-30 → 2035-08-10 2. primary completion date: 2029-03-30 → 2035-08-10 3. enrollment: not set → 130 participants
Clinical trial NCT06814145 updates: 1. completion date: 2029-03-30 → 2035-08-10 2. primary completion date: 2029-03-30 → 2035-08-10 3. enrollment: not set → 130 participants
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical